The programmed cell death protein 1 (PD1) and the programmed cell death ligand 1 (PD-L1) are significantly downregulated on macrophages and Hofbauer cells in the placenta of preeclampsia patients

被引：0
|
作者：
Mittelberger, Johanna [1 ]
Seefried, Marina [1 ]
Loeb, Sanja [2 ]
Kuhn, Christina [1 ]
Franitza, Manuela [1 ]
Garrido, Fabian [1 ]
Wild, Carl Mathis [1 ]
Ditsch, Nina [1 ]
Jeschke, Udo [1 ]
Dannecker, Christian [1 ]
机构：
[1] Univ Hosp Augsburg, Gynecol & Obstet, Augsburg, Germany
[2] Univ Hosp Wurzburg, Gynecol & Obstet, Wurzburg, Germany
来源：
JOURNAL OF REPRODUCTIVE IMMUNOLOGY | 2023年 / 159卷
关键词：
D O I：
10.1016/j.jri.2023.104076
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [1] The programmed cell death protein 1 (PD1) and the programmed cell death ligand 1 (PD-L1) are significantly downregulated on macrophages and Hofbauer cells in the placenta of preeclampsia patients
    Mittelberger, Johanna
    Seefried, Marina
    Loeb, Sanja
    Kuhn, Christina
    Franitza, Manuela
    Garrido, Fabian
    Wild, Carl Mathis
    Ditsch, Nina
    Jeschke, Udo
    Dannecker, Christian
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2023, 157
  • [2] Regulation of Programmed cell Death Protein 1 (PD1)/Programmed Death-Ligand 1 (PD-L1) in HIV-1 infection, and Therapeutic Prevention
    Haorah, James
    Mishra, Vikas
    Schuetz, Heather
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S56 - S56
  • [3] Significant Downregulation of PD1 and PD-L1 on Macrophages and Hofbauer Cells in Placenta of Patients with Preeclampsia
    Mittelberger, J.
    Jeschke, U.
    Dannecker, C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (06) : 745 - 745
  • [4] Binding Free Energy Analysis of Programmed Cell Death Protein PD1 to its Ligand PD-L1
    Pan, Peter C.
    Tafazzol, Alireza
    Zhang, Xianwei
    Duan, Yong
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 477A - 477A
  • [5] BINDING FREE ENERGY ANALYSIS OF PROGRAMMED CELL DEATH PROTEIN PD1 TO ITS LIGAND PD-L1
    Pan, Peter
    Tafazzol, Alireza
    Zhang, Xianwei
    Duan, Yong
    NEURO-ONCOLOGY, 2018, 20 : 67 - 67
  • [6] Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
    Abaza, Abdelrahman
    Idris, Faten Sid
    Shaikh, Humna Anis
    Vahora, Ilma
    Moparthi, Kiran Prasad
    Al Rushaidi, Majdah T.
    Muddam, Meghana Reddy
    Obajeun, Omobolanle A.
    Jaramillo, Arturo P.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [7] Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment
    Jomrich, Gerd
    Kollmann, Dagmar
    Ramazanova, Dariga
    Ristl, Robin
    Grose, Richard P.
    Ilhan-Mutlu, Ayseguel
    Preusser, Matthias
    Fassnacht, Christina
    Tsai, Yi-Chien
    Guenova, Emmanuella
    Schoppmann, Sebastian F.
    EJSO, 2022, 48 (02): : 383 - 390
  • [8] Programmed Cell Death 1 Ligand 1 (PD-L1) Expression in Thymoma
    Yokoyama, Shintaro
    Miyoshi, Hiroaki
    Nishi, Tatsuya
    Matsumoto, Ryouichi
    Hashiguchi, Toshihiro
    Murakami, Daigo
    Kashihara, Masaki
    Takamori, Shinzo
    Akagi, Yoshito
    Ohshima, Koichi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S503 - S503
  • [9] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Matsuda, Kotaro
    Miyoshi, Hiroaki
    Hiraoka, Koji
    Hamada, Tetsuya
    Yoshida, Shiro
    Ishibashi, Yukinao
    Haraguchi, Toshiaki
    Shiba, Naoto
    Ohshima, Koichi
    CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (04) : 487 - 494
  • [10] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Kotaro Matsuda
    Hiroaki Miyoshi
    Koji Hiraoka
    Tetsuya Hamada
    Shiro Yoshida
    Yukinao Ishibashi
    Toshiaki Haraguchi
    Naoto Shiba
    Koichi Ohshima
    Clinical and Experimental Medicine, 2018, 18 : 487 - 494
12345